Protocol for the development of a tool (INSPECT-SR) to identify problematic randomised controlled trials in systematic reviews of health interventions
Jack Wilkinson(Manchester Academic Health Science Centre), Jamie J Kirkham(University of Liverpool), Lisa Parker(The University of Sydney), Ella Flemyng(The University of Sydney), Alison Avenell(University of Aberdeen), Kyle Sheldrick(UNSW Sydney), Andrew Grey(University of Auckland), Madelon van Wely(Amsterdam University Medical Centers), Calvin Heal(Manchester Academic Health Science Centre), Kylie E Hunter(The University of Sydney), Žarko Alfirević(University of Liverpool), Steph Grohmann(Cochrane), Jo C Dumville(Manchester Academic Health Science Centre), Sarah Lensen(Royal Women's Hospital), Nicholas J. L. Brown(Linnaeus University), Lyle C. Gurrin(The University of Melbourne), Lisa Bero(University of Colorado Anschutz Medical Campus), Emily Lam(Sunnybrook Health Science Centre), Jill A. Hayden(Northwestern University), Emma Sydenham(Cochrane), Elizabeth Loder(Brigham and Women's Hospital), Anna Lene Seidler(The University of Sydney), Patrick Dicker(Royal College of Surgeons in Ireland), Toby J Lasserson, James Heathers(Northeastern University), Mike Clarke(University College Dublin), Tianjing Li(Johns Hopkins University), Gideon Meyerowitz‐Katz(Manchester University NHS Foundation Trust), Rui Wang(Monash University), J. B. Carlisle(Torbay Hospital), Barbara K. Redman(New York University), Neil E O’Connell(Brunel University of London), Ben W. Mol(University of Aberdeen), Wentao Li(Kaiser Permanente South Sacramento Medical Center), George Α. Antoniou, David Torgerson(University of York), Andreas Lundh(Odense University Hospital)
Cited by 40
Related Papers
TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods
|BMJ|2024|2.8k
Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force
|Value in Health|2013|2.1k
A minimal common outcome measure set for COVID-19 clinical research
|The Lancet Infectious Diseases|2020|1.8k
Industry sponsorship and research outcome
|Cochrane Database of Systematic Reviews|2017|1.6k